VIVIDION THERAPEUTICS, INC.
Profile
Company Names
VIVIDION THERAPEUTICS, INC.
Addresses
5820 NANCY RIDGE DR., SAN DIEGO, CA 92121
230 NASSAU STREET, PRINCETON, NJ 08542
Phone Numbers
(858) 345-4690
6099246452
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$240,704,642.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-02-18
$135,000,015.00
$135,000,015.00
$0.00
Equity
3
2019-04-24
$82,000,011.00
$82,000,011.00
$0.00
Equity
2
2017-01-03
$20,200,000.00
$50,500,000.00
$30,300,000.00
Equity
1
2016-03-31
$3,504,616.00
$4,000,000.00
$495,384.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICIA
L.
ALLEN
EXECUTIVE OFFICER
FRED
ASLAN
EXECUTIVE OFFICER
KRISTINA
BUROW
DIRECTOR
KILIMANJARO ENERGY, INC.
| LIMERICK BIOPHARMA INC
| RECEPTOS, INC.
| TRELYS, INC.
| CENEXYS, INC.
| LYCERA CORP
| ARCH VENTURE FUND VIII, L.P.
| AGBIOME, LLC
| METACRINE, INC.
| SIENNA LABS, INC.
| SCHOLAR ROCK LLC
| UNITY BIOTECHNOLOGY, INC.
| ARCH VENTURE FUND IX, L.P.
| BORAGEN, INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| VIVIDION THERAPEUTICS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| BOUNDLESS BIO, INC.
| ARCH VENTURE FUND XI, L.P.
| TREELINE BIOSCIENCES, INC.
| ARCH VENTURE FUND XII, L.P.
| NEUMORA THERAPEUTICS, INC.
| MIRADOR THERAPEUTICS, INC.
| AUTOBAHN THERAPEUTICS, INC.
| METSERA, INC.
JOHN
CLARKE
DIRECTOR
ETRUSCAN RESOURCES INC.
| CGX ENERGY INC.
| BANRO CORP
| ABIDE THERAPEUTICS, INC.
| AMERICAN BIOCARE, INC.
| GLORI ENERGY INC.
| TECHLI, LLC
| HANSTON INSURANCE AGENCY INC
| ALLIED DOWNHOLE TECHNOLOGIES, LLC
| GLORI ENERGY INC.
| FLARE INVESTORS II, LP
| FLARE INDUSTRIES, LLC
| CIMARRON ENERGY HOLDCO INC.
| IVENIX, INC.
| VIVIDION THERAPEUTICS, INC.
| CUREATR INC.
| BLOCKCHAIN TECHNOLOGIES, INC.
| AVINGTRANS PLC
| ZOOMCAR HOLDINGS, INC.
| ALPHA EXPLORATION LTD.
JOHN
K.
CLARKE
EXECUTIVE OFFICER, DIRECTOR
BENJAMIN
CRAVATT
DIRECTOR
JEFFREY
HATFIELD
EXECUTIVE OFFICER, DIRECTOR
RICHARD
HEYMAN
DIRECTOR
JAKOB
LOVEN
DIRECTOR
JOHN
PARK
EXECUTIVE OFFICER, DIRECTOR
THOMAS
WOIWODE
DIRECTOR
EURO VENTURES 4, INC.
| AUDENTES THERAPEUTICS, INC.
| KANYOS BIO, INC.
| INCEPTION IBD, INC.
| CRISPR THERAPEUTICS AG
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| VERSANT VENTURE CAPITAL VI, L.P.
| TEMPEST THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| VERSANT VENTURE CAPITAL VII, L.P.
| VIVIDION THERAPEUTICS, INC.
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| LYCIA THERAPEUTICS, INC.
| JENGU THERAPEUTICS, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| SANTA ANA BIO, INC.
| TEMPEST THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

